Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 1
Author: Axis Direct

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1211.4000 10.60 (0.88%)

NSE Aug 08, 2025 15:31 PM

Volume: 2.4M

Dr. Reddy's Laboratories Ltd.

27 Feb 2017

1211.40

0.88%

Company Update:Dr Reddys Labs

Sell: Dr. Reddy's Laboratories Ltd.

Axis Direct

US District Court has ruled that Dr Reddy's (DRRD) NDA (505 (b)(2))for Aloxi (Palonosetron) infringes 3 outstanding patents and also turned down its claim's to invalidate 2 patents.

Deven Choksey released a Sell report for Dr. Reddy's Laboratories Ltd. with a price target of 1120.0 on 29 Jul, 2025.